logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Migraine Disorders

    FiltersReset Filters
    44 results

    • aimovig

      (erenumab-aooe)
      Amgen Inc
      Usage: AIMOVIG is indicated for the preventive treatment of migraines in adults.

    • ajovy

      (fremanezumab-vfrm)
      Teva Pharmaceuticals USA, Inc.
      Usage: AJOVY is indicated for the preventive treatment of migraine in adults and for episodic migraine in pediatric patients aged 6 to 17 years who weigh 45 kg or more.

    • cambia

      (diclofenac potassium)
      Assertio Therapeutics, Inc.
      Usage: CAMBIA is indicated for the acute treatment of migraine attacks with or without aura in adults aged 18 and older. It is not intended for prophylactic therapy of migraine or for the treatment of cluster headache.

    • depakote

      (Divalproex Sodium)
      AbbVie Inc.
      Usage: Depakote ER is indicated for treating acute manic or mixed episodes of bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. It is not effective for acute migraine treatment. Considerations regarding pregnancy and potential risks are crucial for women of childbearing potential.

    • diclofenac potassium

      (DICLOFENAC POTASSIUM)
      Leading Pharma, LLC
      Usage: Diclofenac Potassium is indicated for the acute treatment of migraine attacks with or without aura in adults. It is not intended for prophylactic therapy of migraines or for treating cluster headaches, as its safety and effectiveness for that condition have not been established.

    • diclofenac potassium

      (DICLOFENAC POTASSIUM)
      Torrent Pharmaceuticals Limited
      Usage: Diclofenac potassium for oral solution is indicated for the acute treatment of migraine attacks in adults (18 years and older), with or without aura. It is not intended for migraine prophylaxis or for treating cluster headaches.

    • dihydroergotamine mesylate nasal

      (Dihydroergotamine Mesylate Nasal)
      Cipla USA Inc.
      Usage: Dihydroergotamine mesylate nasal spray is indicated for the acute treatment of migraine headaches, with or without aura. It is not intended for prophylactic therapy or for managing hemiplegic or basilar migraines.

    • divalproex sodium

      (Divalproex Sodium)
      Aurobindo Pharma Limited
      Usage: Divalproex sodium delayed-release tablets are indicated for treating manic episodes in bipolar disorder, as well as for monotherapy and adjunctive therapy in epilepsy (complex partial and absence seizures). They are also used for migraine prophylaxis but not for acute treatment. Not suitable for pregnant women or those planning pregnancy.

    • divalproex sodium

      (Divalproex sodium)
      NorthStar RxLLC
      Usage: Divalproex sodium extended-release tablets are indicated for treating acute manic or mixed episodes of bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. Long-term effectiveness in mania is unproven, and the drug is contraindicated in pregnant women due to potential fetal risks.

    • divalproex sodium

      (Divalproex Sodium)
      Unichem Pharmaceuticals (USA), Inc.
      Usage: Divalproex sodium delayed-release tablets are indicated for the treatment of manic episodes in bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. Its use in pregnant women or women planning pregnancy is restricted due to potential fetal risks.